Kexing Biopharm 's Overseas Commercial Product Albumin-Bound Paclitaxel with Marketing Approval in the Dominican Republic

Kexing Biopharm’s anti-tumor product, Apexelsin® (Paclitaxel for injection,albumin-bound)has made new progress in its international expansion .It has been officially approved for marketing in the Dominican Republic, marking a further expansion of its global market…

View More Kexing Biopharm 's Overseas Commercial Product Albumin-Bound Paclitaxel with Marketing Approval in the Dominican Republic